Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Cheerful gut bug has relationship with antidepressant

Sep. 10, 2019

Passage Bio licenses gene therapy program for CMT2A from Penn

Sep. 9, 2019

Acadia's phase III study of pimavanserin in dementia-related psychosis meets primary endpoint

Sep. 9, 2019

Boehringer Ingelheim, Hydra Biosciences patent TRPC6 antagonists

Sep. 9, 2019

CAD-1883 demonstrates promising safety in phase I study

Sep. 6, 2019

An organoid model for prenatal brain development

Sep. 6, 2019

Tonix begins phase I study of TNX-601 for daytime treatment of PTSD

Sep. 5, 2019

Biogen explores non-covalent activation of NRF2 for neurodegenerative and other disorders

Sep. 4, 2019

Vulnerable brains can be steered towards healthy development

Sep. 4, 2019

Grunenthal and UniQuest establish neuropathic pain collaboration

Sep. 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...